SHC logo

Sotera Health Company (SHC)

$16.28

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SHC

Market cap

$4.65B

EPS

0.6

P/E ratio

31.6

Price to sales

4.24

Dividend yield

--

Beta

1.943573

Price on SHC

Previous close

$16.05

Today's open

$15.99

Day's range

$15.97 - $16.41

52 week range

$13.09 - $19.85

Profile about SHC

CEO

Michael B. Petras

Employees

3000

Headquarters

Broadview Heights, OH

Exchange

Nasdaq Global Select

Shares outstanding

285630846

Issue type

Common Stock

SHC industries and sectors

Healthcare

Medical Diagnostics & Screening

News on SHC

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 18, 2026

news preview

Do Options Traders Know Something About Sotera Health Stock We Don't?

Investors need to pay close attention to SHC stock based on the movements in the options market lately.

news source

Zacks Investment Research • Nov 12, 2026

news preview

What Sotera Health (SHC) Said on Its Q3 Earnings Call

Sotera Health NASDAQ: SHC reported third-quarter 2026 revenue growth and higher adjusted EBITDA, while reaffirming its full-year outlook despite softer demand from medical-device customers in Europe that emerged late in the quarter and continued into the start of the fourth quarter.

news source

MarketBeat • Nov 3, 2026

news preview

Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript

Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 3, 2026

news preview

Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results

Q3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis (1) , compared to Q3 2025 Q3 2026 net income of $58 million or $0.20 per diluted share Q3 2026 Adjusted EBITDA ( 1 ) increased 3.9%, or 4.0% on a constant currency basis Q3 2026 Adjusted EPS (1) of $0.29, an increase of 12% per diluted share Reaffirming full-year 2026 net revenues growth outlook of 5.25% - 6.75% and Adjusted EBITDA growth outlook of 5.75% - 7.25%, both on a constant currency basis CLEVELAND, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and nine-months ended September 30, 2026. “We are pleased with our third-quarter performance, which included solid top- and bottom-line constant currency growth, along with nearly 100 basis points of sequential Adjusted EBITDA margin expansion,” said Alton Shader, Chief Executive Officer.

news source

GlobeNewsWire • Nov 3, 2026

news preview

Sotera Health Company (SHC) Beats Q3 Earnings and Revenue Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago.

news source

Zacks Investment Research • Nov 3, 2026

news preview

Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Nov 3, 2026

news preview

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m.

news source

GlobeNewsWire • Oct 21, 2026

news preview

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.

news source

Seeking Alpha • Sep 18, 2026

news preview

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

news source

Seeking Alpha • Sep 9, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Sotera Health Company

Open an M1 investment account to buy and sell Sotera Health Company commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SHC on M1